An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy
dc.authorid | Sevindik, Omur Gokmen/0000-0001-9636-4113 | |
dc.authorid | Mastanzade, Metban/0000-0002-2281-5978 | |
dc.authorid | kirkizlar, onur/0000-0001-7523-8599 | |
dc.authorwosid | Sevindik, Omur Gokmen/AAD-5452-2021 | |
dc.authorwosid | Mastanzade, Metban/AAE-3938-2020 | |
dc.authorwosid | kirkizlar, onur/W-9594-2018 | |
dc.contributor.author | Sevindik, Omur Gokmen | |
dc.contributor.author | Ozkurt, Zubeyde Nur | |
dc.contributor.author | Boga, Can | |
dc.contributor.author | Besisik, Sevgi Kalayoglu | |
dc.contributor.author | Ipek, Yildiz | |
dc.contributor.author | Geduk, Ayfer | |
dc.contributor.author | Harmandali, Aybuke | |
dc.date.accessioned | 2023-01-12T20:22:17Z | |
dc.date.available | 2023-01-12T20:22:17Z | |
dc.date.issued | 2021 | |
dc.department | N/A/Department | en_US |
dc.description.abstract | [No Abstract Available] | en_US |
dc.identifier.endpage | S103 | en_US |
dc.identifier.issn | 2152-2650 | |
dc.identifier.issn | 2152-2669 | |
dc.identifier.issn | 2152-2650 | en_US |
dc.identifier.issn | 2152-2669 | en_US |
dc.identifier.startpage | S102 | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/79386 | |
dc.identifier.volume | 21 | en_US |
dc.identifier.wos | WOS:000717640800179 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Cig Media Group, Lp | en_US |
dc.relation.ispartof | Clinical Lymphoma Myeloma & Leukemia | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy | en_US |
dc.type | Conference Object | en_US |